Surveillance

This annual surveillance report, summarizes information about reported cases of hepatitis A, hepatitis B, and hepatitis C and deaths with either of these hepatitis listed as a cause of death in CDC’s National Vital Statistics System (NVSS).

This fact sheet summarizes global goals and targets for TB control. The fact sheet also contains a data table with demographic, epidemiological, and operational indicators; threats to TB control; and resources for all the countries in the Americas.

This book describes the technical framework and principles used to implement DOTS-Plus in resource poor settings. It also provides a number of case histories that illustrate common challenges in the treatment of MDR TB patients. The book includes protocols that can be used under DOTS-Plus program conditions to manage common complication of this therapy.

This fact sheet presents data of the distribution on TB cases among the population of Los Angeles County in 2003.

This report summarizes data from the national TB surveillance system for 2004 and describes trends since 1993. Findings indicate that although the 2004 TB rate was the lowest recorded in the United States since national reporting began in 1953, the declines in rates for 2003 (2.3%) and 2004 (3.3%) were the smallest since 1993. TB rates greater than the US average continue to be reported in certain racial/ethnic populations.

This instructional packet includes a series of four print-based modules addressing TB contact investigation, case management, and confidentiality. It also provides information on managing multidrug-resistant TB and on DOT.

This report, updated annually, details the global epidemiology of TB based on the data supplied by the national TB programs from WHO member states.

These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.

This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.

This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.